We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$11.2B
AUM Growth
+$940M
Cap. Flow
+$1.12B
Cap. Flow %
10.03%
Top 10 Hldgs %
10.74%
Holding
2,900
New
574
Increased
959
Reduced
752
Closed
610

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$93.4M
2
AAPL icon
Apple
AAPL
+$80.7M
3
DRI icon
Darden Restaurants
DRI
+$70M
4
CVS icon
CVS Health
CVS
+$63.6M
5
V icon
Visa
V
+$54.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 20.85%
2 Technology 11.68%
3 Financials 10.7%
4 Healthcare 9.66%
5 Industrials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZVO
2251
DELISTED
Zovio Inc. Common Stock
ZVO
$46K ﹤0.01%
+23,245
New +$69.9K
AQMS icon
2252
Aqua Metals
AQMS
$9.63M
$45K ﹤0.01%
131
-149
-53% -$54.4K
OCUL icon
2253
Ocular Therapeutix
OCUL
$1.86B
$44K ﹤0.01%
+14,348
New +$64.1K
DNR
2254
DELISTED
Denbury Resources, Inc.
DNR
$44K ﹤0.01%
36,920
-32,446
-47% -$37.4K
KG
2255
Kestrel Group
KG
$71.3M
$43K ﹤0.01%
2,860
-1,313
-31% -$15.4K
AVXL icon
2256
Anavex Life Sciences
AVXL
$222M
$40K ﹤0.01%
+12,631
New +$36.4K
BLCM
2257
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$40K ﹤0.01%
3,791
-5,466
-59% -$71.4K
VERU icon
2258
Veru
VERU
$36.1M
$39K ﹤0.01%
+1,787
New +$37.2K
SER icon
2259
Serina Therapeutics
SER
$31M
$38K ﹤0.01%
+554
New +$52.5K
KA
2260
DELISTED
Kineta, Inc. Common Stock
KA
$38K ﹤0.01%
318
+122
+62% +$14.5K
WPRT
2261
Westport Fuel Systems
WPRT
$36.4M
$36K ﹤0.01%
+1,319
New +$37.5K
ACGN
2262
DELISTED
Aceragen Inc
ACGN
$36K ﹤0.01%
743
-165
-18% -$7.25K
OESX icon
2263
Orion Energy Systems
OESX
$41.1M
$35K ﹤0.01%
+1,231
New +$35.2K
NTGN
2264
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$35K ﹤0.01%
+20,482
New +$62.3K
LFT
2265
Lument Finance Trust
LFT
$41.9M
$34K ﹤0.01%
10,008
-20,092
-67% -$66.9K
MUX icon
2266
McEwen Inc
MUX
$1.03B
$34K ﹤0.01%
+2,205
New +$40.1K
TRQ
2267
DELISTED
Turquoise Hill Resources Ltd
TRQ
$34K ﹤0.01%
7,085
+223
+3% +$1.34K
VRAY
2268
DELISTED
ViewRay, Inc.
VRAY
$32K ﹤0.01%
10,997
-3,245
-23% -$19.2K
VSTM icon
2269
Verastem
VSTM
$532M
$25K ﹤0.01%
1,703
+330
+24% +$5.36K
QHC
2270
DELISTED
Quorum Health Corporation
QHC
$23K ﹤0.01%
+18,863
New +$25.5K
ALT icon
2271
Altimmune
ALT
$539M
$22K ﹤0.01%
11,248
-10,272
-48% -$22.8K
LUMO
2272
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$21K ﹤0.01%
+1,498
New +$22K
SEEL
2273
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$21K ﹤0.01%
6
-1
-14% -$6.03K
TALO.WS
2274
DELISTED
Talos Energy, Inc. Warrants to purchase common stock (expiring February 28, 2021)
TALO.WS
$19K ﹤0.01%
19,146
BAS
2275
DELISTED
Basis Energy Services, Inc.
BAS
$19K ﹤0.01%
12,998
-3,514
-21% -$5.89K

Similar funds

Squarepoint's Q3 2019 Portfolio in Review

As of Q3 2019, Squarepoint held 2,900 positions worth $11.2B, up 9.2% from $10.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Squarepoint deployed $1.12B of net new capital in Q3 2019, opening 574 new positions and adding to 959 existing holdings. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 3,258,265 shares worth $161M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, down from 21% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Celgene Corp, an estimated $93.4M trimmed.

  • Squarepoint's largest Q3 2019 buy was State Street Communication Services Select Sector SPDR ETF: 3,258,265 shares worth $161M.
  • Squarepoint added most to Costco in Q3 2019, an estimated $137M increase.
  • Squarepoint's biggest Q3 2019 reduction was Celgene Corp, cutting an estimated $93.4M.
  • Squarepoint fully exited Visa in Q3 2019, selling an estimated $54.9M.
  • Squarepoint's ten largest holdings make up 11% of its $11.2B portfolio in Q3 2019.
  • Squarepoint opened 574 new positions and closed 610 in Q3 2019.
  • Squarepoint's portfolio value rose 9.2% quarter-over-quarter to $11.2B.

Based on Squarepoint's 13F filing for Q3 2019, filed 14 Nov 2019.